Procurement
This decision point features guides for identifying and prioritizing problems within health care delivery organizations and surfacing stakeholders affected by problems. Also includes guides for determining different dimensions of problems and assessing the suitability of AI as a technical approach to address problems.
Guides
This decision point features guides for how organizations can assess the feasibility and viability of adopting AI to solve problems. Also includes guides for conducting preliminary assessments of AI products, assessing legal risks of AI product adoption, and auditing the process by which AI product investments are made.
Guides
Development
This decision point features guides for defining the scope of use, constraints, and dependencies of AI products. Also includes guides for defining technical performance targets for AI products as well as measures of success for AI products used in practice.
Guides
This decision point features guides for how organizations design and test optimal workflows for clinician-facing AI products. Also includes guides for adapting pre-existing operational structures, workflows, and technologies to enable successful integration of AI products.
Guides
This decision point features guides for locally validating AI products before clinical use and identifying foreseeable and unresolved risks resulting from AI use in clinical care. Also includes guides for determining if AI products should be clinically integrated or abandoned.
Guides
Integration
This decision point features guides for disseminating information about AI products to affected clinicians and managing changes in the work environment caused by AI products put into clinical use. Also includes guides for preventing inappropriate use of AI products beyond their intended scope.
Guides
Lifecycle Management
This decision point features guides for monitoring AI solutions and affected work environments over time and sustaining improved outcomes achieved through AI use. Also includes guides for conducting audits of AI products that complement ongoing monitoring and proactively identifying risks not envisioned at the time of clinical integration.
Guides
This decision point features guides for updating or decommissioning AI products, adapting work environments affected by AI use, and expanding the use of AI products to new settings. Also includes guides for minimizing disruptions and harms that result from decommissioning AI products and disseminating information about AI product updates to affected clinicians.